Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06665672 · ClinicalTrials.gov registry record · NA

Effect of a Wrist-worn Device That Produces a Small Vibration on Sleep and Performance That Can Occur During and After Night Shift Work

A NA study of Sleep Duration and Psychomotor Performance, sponsored by Daniel Patterson, PhD, NRP.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT06665672 is a NA study of Sleep Duration and Psychomotor Performance that is actively recruiting participants, run by Daniel Patterson, PhD, NRP. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06665672, a NA study of Sleep Duration and Psychomotor Performance, is actively recruiting participants, sponsored by Daniel Patterson, PhD, NRP.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The overarching goal of this research study is to determine "proof of concept" of effect of a non-invasive sleep aid device on sleep and performance during sleep opportunities (naps) that occur during and after simulated night shift work. Aim 1: To determine the effect of the ApolloNeuro device on sleep duration, sleep architecture, blood pressure, heart rate variability, and subjective ratings of sleep quality during and after simulated night shift work. Aim 2: To determine the effect of the ApolloNeuro device on post-sleep psychomotor performance.

Interventions

  • DEVICE Wrist worn vibro-acoustic device

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2024-11-26
Est. Completion 2026-03-31
Phase NA

Sponsor

Daniel Patterson, PhD, NRP

1 total trials

What the Registry Record Tells You About NCT06665672

The ClinicalTrials.gov registry entry for NCT06665672 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Daniel Patterson, PhD, NRP, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Sleep Duration appearing as the primary indexed condition, and to 1 intervention - of which Wrist worn vibro-acoustic device is the first listed.

NCT06665672 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06665672 about?

NCT06665672 is a clinical study titled "Effect of a Wrist-worn Device That Produces a Small Vibration on Sleep and Performance That Can Occur During and After Night Shift Work". The overarching goal of this research study is to determine "proof of concept" of effect of a non-invasive sleep aid device on sleep and performance during sleep opportunities (naps) that occur during and after simulated night shift work. Aim 1: To determine the effect of the ApolloNeuro device on ...

What is the current status of trial NCT06665672?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2024-11-26. Estimated completion is 2026-03-31.

What conditions does trial NCT06665672 study?

This clinical trial studies the following conditions: Sleep Duration, Psychomotor Performance.

What interventions are being tested in trial NCT06665672?

The interventions under investigation include: Wrist worn vibro-acoustic device (DEVICE).

Who is sponsoring clinical trial NCT06665672?

This trial is sponsored by Daniel Patterson, PhD, NRP, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06665672 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Duration

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.